BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32134701)

  • 1. State of the Art: Toward Improving Outcomes of Lung and Liver Tumor Biopsies in Clinical Trials-A Multidisciplinary Approach.
    Levy EB; Fiel MI; Hamilton SR; Kleiner DE; McCall SJ; Schirmacher P; Travis W; Kuo MD; Suh RD; Tam AL; Islam SU; Ferry-Galow K; Enos RA; Doroshow JH; Makhlouf HR
    J Clin Oncol; 2020 May; 38(14):1633-1640. PubMed ID: 32134701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network.
    Abrams J; Conley B; Mooney M; Zwiebel J; Chen A; Welch JJ; Takebe N; Malik S; McShane L; Korn E; Williams M; Staudt L; Doroshow J
    Am Soc Clin Oncol Educ Book; 2014; ():71-6. PubMed ID: 24857062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations for collection and handling of specimens from group breast cancer clinical trials.
    Leyland-Jones BR; Ambrosone CB; Bartlett J; Ellis MJ; Enos RA; Raji A; Pins MR; Zujewski JA; Hewitt SM; Forbes JF; Abramovitz M; Braga S; Cardoso F; Harbeck N; Denkert C; Jewell SD; ; ; ; ; ; ; ; ; ; ; ;
    J Clin Oncol; 2008 Dec; 26(34):5638-44. PubMed ID: 18955459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving Adequacy of Small Biopsy and Fine-Needle Aspiration Specimens for Molecular Testing by Next-Generation Sequencing in Patients With Lung Cancer: A Quality Improvement Study at Dartmouth-Hitchcock Medical Center.
    Padmanabhan V; Steinmetz HB; Rizzo EJ; Erskine AJ; Fairbank TL; de Abreu FB; Tsongalis GJ; Tafe LJ
    Arch Pathol Lab Med; 2017 Mar; 141(3):402-409. PubMed ID: 27763790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward Improving Practices for Submission of Diagnostic Tissue Blocks for National Cancer Institute Clinical Trials.
    Makhlouf H; Watson MA; Lankes HA; Weil C; Dickler M; Birrer M; Moskaluk C; Ramirez NC; Okby N; Alonsozana E; Barnes M; Goldman EB; Enos R; Lubensky I
    Am J Clin Pathol; 2020 Jan; 153(2):149-155. PubMed ID: 31613330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical Care Network in the State of Qatar.
    Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
    Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guidelines for the development and incorporation of biomarker studies in early clinical trials of novel agents.
    Dancey JE; Dobbin KK; Groshen S; Jessup JM; Hruszkewycz AH; Koehler M; Parchment R; Ratain MJ; Shankar LK; Stadler WM; True LD; Gravell A; Grever MR;
    Clin Cancer Res; 2010 Mar; 16(6):1745-55. PubMed ID: 20215558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiologic Considerations and Standardization of Malignant Pleural Mesothelioma Imaging Within Clinical Trials: Consensus Statement from the NCI Thoracic Malignancy Steering Committee - International Association for the Study of Lung Cancer - Mesothelioma Applied Research Foundation Clinical Trials Planning Meeting.
    Gill RR; Tsao AS; Kindler HL; Richards WG; Armato SG; Francis RJ; Gomez DR; Dahlberg S; Rimner A; Simone CB; de Perrot M; Blumenthal G; Adjei AA; Bueno R; Harpole DH; Hesdorffer M; Hirsch FR; Pass HI; Yorke E; Rosenzweig K; Burt B; Fennell DA; Lindwasser W; Malik S; Peikert T; Mansfield AS; Salgia R; Yang H; Rusch VW; Nowak AK
    J Thorac Oncol; 2019 Oct; 14(10):1718-1731. PubMed ID: 31470129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learned from clinical trial queries on small biopsy collections: importance of rapid on-site evaluation.
    Voyten J; Holtzman MP; Pantanowitz L; Dhir R; Beasley HS; Cuda J; Monaco SE
    J Am Soc Cytopathol; 2020; 9(5):461-468. PubMed ID: 32499137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility, safety, and adequacy of research biopsies for cancer clinical trials at an academic medical center.
    Lee K; Lee SJ; Yoon S; Ryoo BY; Kim SW; Choi SH; Lee SM; Chae EJ; Park Y; Jang SJ; Park SY; Yoon YK; Park SH; Kim TW
    PLoS One; 2019; 14(8):e0221065. PubMed ID: 31404103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining the Optimal Number of Core Needle Biopsy Passes for Molecular Diagnostics.
    Hoang NS; Ge BH; Pan LY; Ozawa MG; Kong CS; Louie JD; Shah RP
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):489-495. PubMed ID: 29279975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
    Rivera MP; Mehta AC; Wahidi MM
    Chest; 2013 May; 143(5 Suppl):e142S-e165S. PubMed ID: 23649436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid fine needle aspiration cytology: a review of the National Cancer Institute state of the science symposium.
    Layfield LJ; Cibas ES; Baloch Z
    Cytopathology; 2010 Apr; 21(2):75-85. PubMed ID: 21054821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consensus report of a joint NCI thoracic malignancies steering committee: FDA workshop on strategies for integrating biomarkers into clinical development of new therapies for lung cancer leading to the inception of "master protocols" in lung cancer.
    Malik SM; Pazdur R; Abrams JS; Socinski MA; Sause WT; Harpole DH; Welch JJ; Korn EL; Ullmann CD; Hirsch FR
    J Thorac Oncol; 2014 Oct; 9(10):1443-8. PubMed ID: 25521397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program.
    Minasian LM; Tangen CM; Wickerham DL
    Semin Oncol; 2015 Oct; 42(5):748-63. PubMed ID: 26433556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of interventional radiology in clinical trial teams: experience from the BATTLE lung cancer trials.
    Tam AL; Papadimitrakopoulou V; Wistuba II; Lee JJ; Ensor JE; Kim ES; Kalhor N; Blumenschein GR; Tsao AS; Heymach JV; Herbst RS; Hicks ME; Hong WK; Gupta S
    Clin Radiol; 2021 Feb; 76(2):155.e25-155.e34. PubMed ID: 33268083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes and efficacy of thoracic surgery biopsy for tumor molecular profiling in patients with advanced lung cancer.
    Cooke DT; Gandara DR; Goodwin NC; Calhoun RF; Lara PN; Mack PC; David EA
    J Thorac Cardiovasc Surg; 2014 Jul; 148(1):36-40. PubMed ID: 24746995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue diagnosis of suspected lung cancer: selecting between bronchoscopy, transthoracic needle aspiration, and resectional biopsy.
    Yung RC
    Respir Care Clin N Am; 2003 Mar; 9(1):51-76. PubMed ID: 12820712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.